Showing results (191-200 of 243) with videos related to
Sort By:
Pageof 25
Blood|February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.Blood|January 15, 2020
Improved transplant survival and long-term disease outcome in children with MHC class II deficiencySu Han Lum, Claire Anderson, Peter McNaughton, et al.Journal of Clinical Immunology|April 21, 2022
Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene TherapyDanielle E Arnold, Deepak Chellapandian, Suhag Parikh, et al.The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.Journal of Clinical Immunology|August 15, 2015
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective AnalysisBeata Wolska-Kuśnierz, Hanna Gregorek, Krystyna Chrzanowska, et al.Blood|March 16, 2025
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective studyQuentin Riller, Mathias Hauri, Su Han Lum, et al.The Journal of Allergy and Clinical Immunology|February 28, 2016
Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytesSwati Naik, Sarah K Nicholas, Caridad A Martinez, et al.Frontiers in Immunology|July 2, 2021
Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII DeficiencyFrancesca Ferrua, Ileana Bortolomai, Elena Fontana, et al.Journal of Clinical Immunology|October 29, 2024
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working PartyHelena Buso, Etai Adam, Peter D Arkwright, et al.Blood|April 26, 2024
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunitySu Han Lum, Michael H Albert, Patrick Gilbert, et al.Pageof 25